12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Palisade™ Pedicular Fixation System

FDA 510(k)
FDA Class 2 ·Orthopedic

PSS SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

T2 GREATER TROCHANTER NAIL

FDA 510(k)
FDA Class 2 ·Orthopedic

INCORPORATE

FDA UDI
SPINAL ELEMENTS·00840606151948·17 X 14 CERVICAL TRIALS 38MM 0° LORDOSIS

INCORPORATE

FDA UDI
SPINAL ELEMENTS·00840606152136·17 X 14 CERVICAL TRIALS 38MM 10° LORDOSIS

PERCLOSE PROGLIDE 6F SUTURE MEDIATED CLOSURE (SMC) SYSTEM

FDA Adverse Event
Injury ·AV-TEMECULA-CT·Product code MGB·October 14, 2014

OT VERIO IQ METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·June 15, 2013

MAXILIFT

FDA Adverse Event
Malfunction ·ARJO MED. AB LTD.·Product code FSA·August 26, 2008

HAART 200 AORTIC ANNULOPLASTY RING

FDA Adverse Event
Injury ·CORCYM INC.·Product code KRH·May 8, 2025

HAART 200 AORTIC ANNULOPLASTY RING

FDA Adverse Event
Injury ·CORCYM INC.·Product code KRH·May 9, 2025

CADD-Solis VIP ambulatory infusion pump, Model Numbers: a. 21-2120-0105-02L b. 21-2120-0105-03L c. 21-2120-0105-06L d. 21-2120-0105-07L e. 21-2120-0105-08L f. 21-2120-0105-12L g. 21-2120-0105-13L h. 21-2120-0105-14L i. 21-2120-0105-15L j. 21-2120-0105-17L k. 21-2120-0105-50L l. 21-2127-0105-02L m. 21-2127-0105-06L n. 21-2127-0105-50L

FDA Enforcement
Class I ·Terminated·Smiths Medical ASD Inc.·October 27, 2021

Merlin PCS Programmer software model 3330, used with Confirm Rx Insertable Cardiac Monitor (ICM), Model DM3500, Sterile. The firm name on the label of the ICM is St. Jude Medical Cardiac Rhythm Management Division, Sylmar, CA. - Product Usage: The Confirm Rx insertable cardiac monitor is designed to detect arrhythmias and wirelessly transmit data to the Merlin.net Patient Care Network. The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical, Cardiac Rhythm Management Division·January 22, 2020